1,10-Phenanthroline → 1-(3-Chloro-phenyl)-3-methanesulfonyl-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one

HRID 892319ノート

反応式

HRID 892319 の反応式
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]3[C:13](=[O:24])[N:14]([C:17]4[CH:22]=[CH:21][C:20](I)=[CH:19][CH:18]=4)[CH2:15][CH2:16][C:11]=3[C:10]([S:25]([CH3:28])(=[O:27])=[O:26])=[N:9]2)[CH:5]=[CH:6][CH:7]=1.[C:29]1(=[O:35])[NH:34][CH2:33][CH2:32][CH2:31][CH2:30]1.C(=O)([O-])[O-].[K+].[K+].N1C2C(=CC=C3C=2N=CC=C3)C=CC=1.[OH-].[NH4+]>ClCCl>[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]3[C:13](=[O:24])[N:14]([C:17]4[CH:22]=[CH:21][C:20]([N:34]5[CH2:33][CH2:32][CH2:31][CH2:30][C:29]5=[O:35])=[CH:19][CH:18]=4)[CH2:15][CH2:16][C:11]=3[C:10]([S:25]([CH3:28])(=[O:27])=[O:26])=[N:9]2)[CH:5]=[CH:6][CH:7]=1

参加物

7

反応物 5

HCID 13181,10-PhenanthrolineHCID 11430Potassium CarbonateHCID 126652-PiperidoneHCID 14923Ammonium HydroxideHCID 222404561-(3-Chloro-phenyl)-6-(4-iodo-phenyl)-3-methanesulfonyl-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one

生成物 1

HCID 102287011-(3-Chloro-phenyl)-3-methanesulfonyl-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one収率 45%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

反応条件

温度
120 °C

実験手順

Part B. In a round bottomed flask were combined 1-(3-chloro-phenyl)-6-(4-iodo-phenyl)-3-methanesulfonyl-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one (1.00 g, 1.89 mmol), δ-valerolactam (0.36 g, 3.79 mmol), anhydrous powdered potassium carbonate (1.05 g, 7.58 mmol), cuprous iodide (0.072 g, 0.38 mmol), and 1,10-phenanthroline (0.068 g, 0.38 mmol). The flask was purge with argon and degassed methylsulfoxide (10 mL) was added before heating to 120° C. Upon completion of the reaction, as judged by TLC or LC/MS, the reaction was cooled to ambient temperature and 50 mL each of 3M ammonium hydroxide and dichloromethane were added. The phases were separated and the aqueous extracted with an additional 30 mL of dichloromethane. The combined dichloromethane extracts are washed successively four times with water and once with brine. The solution was dried over sodium sulfate, filtered, and evaporated to give an oil that was purified by flash column chromatography eluting with ethylacetate to give 0.424 g (45%) of 1-(3-chloro-phenyl)-3-methanesulfonyl-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one as a colorless solid. The material may be recrystallized from acetonitrile. 1H NMR (DMSO-d6) δ 7.79 (t, 1H, J=2 Hz), 7.63–7.49 (m, 3H), 7.32 (ab q, 4H, J=21, 9 Hz), 4.10 (t, 2H, J=6 Hz), 3.58 (t, 2H, J=5 Hz), 3.36 (s, 3H), 3.19 (t, 2H, J=6 Hz), 2.37 (t, 2H, J=5 Hz), 1.83 (m, 4H). LC/MS (ES+): 498.9/500.9 (C1 pattern) (>95% pure by ELSD).

後処理

  1. customIn a round bottomed flask were combined
  2. customThe flask was purge with argon
  3. customdegassed methylsulfoxide (10 mL)
  4. additionwas added
  5. customUpon completion of the reaction
  6. temperaturethe reaction was cooled to ambient temperature
  7. customThe phases were separated
  8. extractionthe aqueous extracted with an additional 30 mL of dichloromethane
  9. washThe combined dichloromethane extracts are washed successively four times with water
  10. dry with materialThe solution was dried over sodium sulfate
  11. filtrationfiltered
  12. customevaporated
  13. customto give an oil that
  14. customwas purified by flash column chromatography
  15. washeluting with ethylacetate

出典と根拠

ORDレコード
ord-9b5d6dd7a0d44a2787df60d696e88b06
出典データセット
uspto-grants-2006_02
特許番号
US07005435B2

反応ノート

読み込み中…